Market Herald logo


Be the first with the news that moves the market

There is one burning topic among the Bullboards of late … the showdown in Washington.

Stocks around the world shave been rocky this week as traders awaited the full results coming from the U.S. midterm elections and crucial consumer data prices that could influence the Federal Reserve’s interest rate policy.

If the balance of power had shifted in the House and Senate, progress in Washington over the next several years, and possibly beyond, could have been impacted.

Government could also be split after the last ballot is cast and traders wonder if this could be good news for the market. More bureaucratic gridlock might mean fewer dramatic policy changes.

The energy market has been hit hard of late, thanks in part to a stronger dollar. Oil and natural gas prices have fallen this week to 1-week lows in many regions across the globe, on China concerns and a jump in in Energy Information Administration crude inventories.

Meanwhile, Trillion Energy International (CSE:TCFForum), an oil and gas company focused on natural gas production for Europe and Turkey, has begun the recompletion of the Akcakoca-3 natural gas well, the second operation in the company’s 17-well, at the South Akcakoca Sub-Basin (SASB) gas field offshore.

On October 31, 2022, the Uranus Rig was repositioned 3 meters while at the Akcakoca Platform to the Akcakoca-3 well slot. The recompletion will replace the bent 2 ½” tubing with 4 ½” tubing, perforating remaining gas zones, upon which time the well will be put back onto production.

The recompletion started on November 1st and is expected to take 12 days. The Akcakoca-3 well originally entered production in March 2011 and has produced 9.78 Bcf of natural gas to date. The well encountered mechanical issues with the production tubing and water build-up and, as a result, has only intermittently produced gas since November 2019. The well is expected to start producing natural gas again immediately upon recompletion

The 27th session of the Conference of the Parties of the UNFCCC (COP 27) was held this week, where a new decarbonization action plan was launched by the U.N.

Decarbonization has been a serious initiative among many companies, such as PyroGenesis Canada (TSXV:PYRForum), who recently announced it  will aid in such efforts of a major international aluminum company. The client is one of the largest aluminum companies worldwide.

PyroGenesis focuses on advanced plasma processes and sustainable solutions to reduce greenhouse gases.

The companies will investigate the feasibility of PyroGenesis’ plasma torches, which are powered entirely by electricity, as a replacement for natural gas in the client’s cast house furnaces.

They have signed a contract to perform an ongoing computational fluid dynamics study, which will help to evaluate plasma in a production-scale furnace to be installed at one of the client’s sites.

Biopharmaceutical company Theratechnologies (TSX:THForum) is rolling out new data from a tissue microarray study which demonstrated high expression of sortilin 1 (SORT1) in solid tumours.

The data highlighted the potential of SORT1 as a new target for the internalization of anticancer therapy and will be used to support the company’s ongoing preclinical and clinical programs of its SORT1+ Technology platform.

SORT1 is a receptor protein that binds to circulating proteins and peptides, which, when used with other therapies, may inhibit the production of cancer cells.

For 257 normal or adjacent tissue cores in the study, SORT1 staining was either negative or low for most healthy tissues, including lung, stomach, liver, ovary, prostate, lymph node, esophagus, small intestine, cervix, skin, spleen, bone marrow, and thymus.

Some healthy tissues had moderate or strong staining, including the colonic mucosa, rectal epithelium, pancreatic islets and vessels, breast lobules, testicular spermatids and Sertoli cells, kidney tubules, and cerebral neuronal cells and astrocytes.

The company intends to further evaluate additional tissue microarrays to increase the biopsy sample size and to broaden the range of tumour types and sub-types that may be susceptible to SORT1.

As we continue into November with focus, an extra hour of sleep courtesy of Daylight Savings Time, and a fresh batch of market activity to dissect, it feels as if every week has been a rollercoaster of news and findings. The next should prove to be no different, so expect the Bullboards to be as lively as ever. We can only capture small fragments of the large dialogue at the Bullboards, so don’t forget to come back to the Bullboards throughout the week to see how the conversations change.

Get “Buzz on the Bullboards” delivered to your inbox every Thursday!

Buzz on the Bullboards | Sign Up Here

More From The Market Herald

" @ the Bell: Industrial, technology gains buoy TSX to open December

Canada’s main stock index closed higher in Thursday trading on strength in the technology sector. The mining and utilities sectors moved lower.
The Market Herald Video

" Stakeholder Gold (TSXV:SRC) shares carbon emissions for Q3,2022

Stakeholder Gold Corporation (SRC) shared Q3 results and announced emissions produced across the company’s operations in Q3 of 2022.
The Market Herald Video

" Calima Energy (ASX:CE1) issues encouraging Q4 drilling update

Calima (CE1) is nearing completion of its five-well drilling campaign at its Brooks property in Calgary.
The Market Herald Video

" RDARS (CSE:RDRS) adds Mesh Mod V1.0 networking to Eagle Watch Platform

RDARS (RDRS) has finalized the development and testing of its patent-pending Eagle Watch Mesh Mod V1.0.